Clinicopathologic correlations of diffuse large B-cell lymphoma in rheumatoid arthritis patients treated with methotrexate

Cancer Science

Volumn 101, Issue 5, 2010, Pages 1309-1313

  Niitsu, Nozomi ^a   Okamoto, Masataka ^b   Nakamine, Hirokazu ^c   Hirano, Masami ^b  

^a SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KANSAI UNIVERSITY OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CD20 ANTIBODY; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOPHENOTYPING; JAPANESE; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REMISSION; RHEUMATOID ARTHRITIS; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; METHOTREXATE; MIDDLE AGED; RNA, VIRAL; TRANSLOCATION, GENETIC;

EID: 77953178322     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01517.x     Document Type: Article

References (27)

1. Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 2004, 50:1740-51.
2. Hoshida Y, Xu JX, Fujita S. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 2007, 34:322-31.
3. Ellman MH, Hurwitz H, Thomas C. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 1991, 18:1741-3.
4. Kingsmore SF, Hall BD, Allen NB. Association of methotrexate, rheumatoid arthritis and lymphoma: report of 2 cases and literature review. J Rheumatol 1992, 19:1462-5.
5. Lioté F, Pertuiset E, Cochand-Priollet B. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection. J Rheumatol 1995, 22:1174-8.
6. Kamel OW, van de Rijn M, Weiss LM. Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 1993, 328:1317-21.
7. Stein H, Warnke RA, Chan WC. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, Volume 2. IARC WHO Classification of Tumours, No 2, Lyon, France, IARC Press
8. Arnett FC, Edworthy SM, Bloch DA. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-24.
9. Hans CP, Weisenburger DD, Greiner TC. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004, 103:275-82.
10. Hashimoto K, Miura I, Chyubachi A. Correlations of chromosome abnormalities with histologic and immunologic characteristics in 49 patients from Akita, Japan with non-Hodgkin lymphoma. Cancer Genet Cytogenet 1995, 81:56-65.
11. Mitelman F. An International System for Human Cytogenetic Nomenclature, ISCN. 1995, Basel, S Karger
12. Cheson BD, Horning SJ, Coiffier B. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999, 17:1244.
13. Shipp MA. International non-Hodgkin's lymphoma prognostic factors project: a predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993, 329:987-94.
14. Niitsu N, Okamoto M, Aoki S. Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma. Ann Haematol 2006, 85:374-80.
15. Baecklund E, Ekbom A, Sparén P. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ 1998, 317:180-1.
16. Salliot C, van der Heijde D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 2009, 68:1100-4.
17. Kamel OW, van de Rijn M, LeBrun DP. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 1994, 25:638-43.
18. Habermann TM. Posttransplant lymphoproliferative disorders. Cancer Treat Res 2008, 142:273-92.
19. Hummel M, Anagnostopoulos I, Korbjuhn P. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types. J Pathol 1995, 175:263-71.
20. Hoshida Y, Tomita Y, Zhiming D. Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection. Int J Cancer 2004, 108:443-9.
21. Delecluse HJ, Kremmer E, Rouault JP. The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders. Am J Pathol 1995, 146:1113-20.
22. Tosato G, Steinberg AD, Yarchoan R. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest 1984, 73:1789-95.
23. Feng WH, Cohen JI, Fischer S. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst 2004, 96:1691-702.
24. Baecklund E, Backlin C, Iliadou A. Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis. Arthritis Rheum 2006, 54:3774-81.
25. Kojima M, Motoori T, Nakamura S. Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients. Biomed Pharmacother 2006, 60:663-72.
26. Kojima M, Motoori T, Itoh H. Distribution of Epstein-Barr virus in systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis) with associated lymphadenopathy: a study of 49 cases. Int J Surg Pathol 2005, 13:273-8.
27. Meijer E, Cornelissen JJ. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients. Curr Opin Hematol 2008, 15:576-85.